This post is presented by our media partner Cannabis News Wire
View the original article here.
Last week, the state of Kentucky awarded the first license for its medical marijuana program to KCA Labs. The state legalized medical marijuana in March 2023, following the signing of SB 47 into law by Governor Andy Beshear. SB 47 legalized the use of medical marijuana for individuals suffering from various debilitating diseases, including multiple sclerosis, cancer, epilepsy, post-traumatic stress disorder, chronic nausea and chronic pain.
Following the legislation’s passage, the governor signed a follow-up measure in April that reduced the timeline for licensing marijuana businesses, allowing the licenses to be awarded this year.
Governor Beshear announced that granting this license was a step toward ensuring patients in the state who suffered from serious diseases had access to tested, safe and high-quality medical marijuana products. The state plans to use a lottery system to grant licenses to businesses focused on the cultivation, processing or sale of medical cannabis. This system also eliminates or reduces the risk of litigation.
It should be noted that no limit has been imposed on the number of licenses that can be awarded to facilities focused on safety compliance, such as KCA Labs, which is a hemp-testing facility. This eliminates the need for a lottery for this category. These facilities are required to test every medical marijuana product before they can be distributed to patients.
Jonathan Thompson, KCA Labs CEO, stated that the company was ready for the task. He added that the company’s extensive knowledge and experience with testing hemp products would translate nicely into the new medical marijuana program.
In his statement, the governor revealed that the lottery to award licenses to processors and growers would occur on Oct. 28, 2024, while that of dispensary licenses would probably take place the following month.
Thus far, the state has received almost 5,000 applications for medical marijuana business licenses. Beshear believes that the lottery is a fair way to give every applicant who gets through the screening process an opportunity to obtain a license. A cap has been imposed on these licenses, however, in order to prevent the market from being flooded with too many products that exceed demand.
The executive director of the medical marijuana program, Sam Flynn, revealed that only 48 dispensary licenses would be issued initially. These licenses would be divided among 11 regions. The medical marijuana program is set to launch on Jan. 1, 2025. It is important to note that the recreational consumption of marijuana in the Commonwealth of Kentucky is still illegal.
The entire marijuana industry, including established companies such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), will be rooting for the successful launch of the cannabis program in Kentucky so that patients in need can readily access the products.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
